KraneShares MSCI All China Health Care Index ETF (KURE)
- Expense ratio0.64%
- Net assets$111.5M
- Dividend yield3.67%
- 1-year return-5.09%
- Holdings40
KURE ETF price chart
KURE quote & trading statistics
KURE performance
Total return · as of October 17, 2026- YTD+4.82%
- 1 year-5.09%
- 3 years+1.72%/yr
- 5 years-9.17%/yr
- 10 years0.00%/yr
- 1Y volatility
- 21.30%
- 3Y volatility
- 26.49%
- 3Y Sharpe ratio
- 0.13
Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.
KURE top 10 holdings
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | 1801 | Innovent Biologics Inc | 8.49% |
| 2 | 2269 | WuXi Biologics | 7.80% |
| 3 | 603259 | WuXi AppTec Co Ltd | 5.83% |
| 4 | 300760 | Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A | 5.08% |
| 5 | 600276 | Jiangsu Hengrui Medicine Co Ltd | 4.74% |
| 6 | 9926 | Akeso Inc | 4.02% |
| 7 | 1093 | CSPC Pharmaceutical Group Ltd | 3.62% |
| 8 | 1177 | Sino Biopharmaceutical Ltd | 3.61% |
| 9 | 2359 | WuXi AppTec Co Ltd H | 3.44% |
| 10 | 3692 | Hansoh Pharmaceutical Group Co Ltd | 2.86% |
The top 10 holdings make up 49.5% of the fund (40 holdings in total). As of October 17, 2026.
About KraneShares MSCI All China Health Care Index ETF
The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.
KURE ETF FAQ
What is the KURE expense ratio?
KraneShares MSCI All China Health Care Index ETF has a net expense ratio of 0.64%, or $64.00 a year for every $10,000 invested.
How much money is in KURE?
KraneShares MSCI All China Health Care Index ETF has about $111.5M in net assets.
What are the top holdings of KURE?
The largest positions in KURE are Innovent Biologics Inc (8.49%), WuXi Biologics (7.80%), WuXi AppTec Co Ltd (5.83%). The fund holds 40 securities in total.
How has KURE performed?
KURE returned -5.09% over the past year and -9.17% a year over the past five years, including reinvested distributions.
Does KURE pay dividends?
KURE has a dividend yield of 3.67%.
When was KURE launched?
KraneShares MSCI All China Health Care Index ETF began trading on January 31, 2018.